Atlas Trials

CART-123 FOR Relapsed/Refractory Acute Myelocytic Leukemia(AML)

Clinical trial NCT03556982 · UNKNOWN

Trial details

NCT number
NCT03556982
Sponsor
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Leukemia, Myeloid, Acute
Start date
2018-03-01
Primary completion
2019-03-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.